SUMMARY. It has been shown that radiochromic ®lm is an ideal dosimeter for assessment and veri®cation of delivered dose to irradiated blood products. Using a parallel opposing two-®eld technique on a medical linear accelerator, blood is irradiated to diminish the risk of transfusion-associated graft vs. host disease (TA-GVHD). The blood products are irradiated in a Perspex blood box to an applied dose of 29´5±31´7 Gy. Veri®cation of applied dose has been performed with thimble ionization chambers and radiochromic ®lm. Radiochromic ®lm results have matched absorbed dose measurements from ionization chambers at all sites within the`active' treatment volume within 6 6% for a 95% con®dence limit. Using a sample of 100 in-vitro measurements, radiochromic ®lm has measured the average applied dose to blood products to be 30´95 6 2´6 Gy for two standard deviations. Like currently availablè irradiated' ®lm labels, the radiochromic ®lm also serves as a visible reminder that the blood products have been irradiated.
Blood products are irradiated using photons to diminish the risk of transfusion-associated graft vs. host disease (TA-GVHD). The desired effect of irradiating the blood is to inhibit lymphocyte function and therefore to prevent GVHD while not causing damage to platelets and other blood fractions. The UK guidelines for blood irradiation state that all parts of the blood pack should receive at least 2500 cGy. These quidelines are based on the work of Pelszynski et al. (1994) and Luban & DePalma (1996) who demonstrated that 2500 cGy achieves a 5log depletion of T cells in a T-cell cologen assay. Leitman (1993) surveyed the status of blood irradiation for TA-GVHD prevention and veri®ed that`at least' 2500 cGy should be suf®cient to prevent GVHD. Moroff et al. (1986) conducted a study on the in-vitro properties of stored platelets and results indicated that 5000 cGy did not signi®cantly alter the platelet number, the mean platelet volume, the response to hypotonic stress, the extent of discharge of lactate hydrogenase from the cytoplasm or the morphological characteristics of the platelets. From these studies, and for ease of treatment, an applied mean dose of 3085 cGy was adopted by our centre for irradiation of blood products, accepting a deviation of up to 6%.
Previous dosimetry techniques
Various dosimetry techniques are mentioned in the literature, including thermoluminescent dosimeters (TLDs), alanine, ferrous sulphate, red perspex, metal oxide semiconductor ®eld effect transistors (MOSFETs) and chloroform/dithoizone/paraf®n mixture (Hillyer et al., 1993) . The most prevalent method relies on TLDs. Often cases are attached to the outside of the blood bags or alternatively placed in polystyrene phantoms which are made to ®t into the cylindrical geometry of the commercially available blood irradiators. Radiation-sensitive labels set to speci®c doses are currently available for use in blood irradiation. However, they only provide information in terms of the minimum dose given to the blood and no quantitative information concerning the actual absorbed dose to the blood products. In this note, Gafchromic MD-55-2 radiochromic ®lm is tested as an alternative method of dosimetry.
MATERIALS AND METHODS
Blood products are irradiated using 6-MV X-rays produced by a Varian 2100C linear accelerator in a 40-cm´40-cm´31´5-cm Perspex`blood box' which is entirely ®lled with bags containing rice during irradiation. The rice has been tested for attenuation properties and the data used to produce a computer-planned treatment sheet on a GE target series II radiotherapy planning computer using two parallel opposed ®elds. An irradiation volume was visibly marked on the`blood box' to allow a variation of less than 6% for applied dose to the blood products. Standard dosimeter measurements were performed with a thimble ionization chamber attached to a Farmer 2570 dosemeter. These results are used in X-ray dosimetry as a standard and accurate method of dose measurement. Dose was mesured in vitro with ISP technologies Gafchromic MD-55-2 radiochromic ®lm. In all instances, measurements were performed using two 1-cm´1-cm square pieces of MD-55-2 Gafchromic ®lm. A control ®lm of the same dimensions from the same piece of ®lm was placed in a light-tight envelope and used in all experiments as a standard for background readings. Optical density of the ®lms was recorded using a 660-nm spot densitometer (Photon Industries, Mangerton, NSW, Australia) and used to determine the absorbed dose to the blood products. This is achieved by comparing the optical density readings to that of previously irradiated ®lms to known doses in control conditions. The ®lm pieces were placed perpendicular to the irradiation beam direction and within the`active' blood volume during irradiation. The X-ray energy response of Gafchromic ®lm has been studied in detail by Kron et al. (1998) . These results show that the ®lm could be used effectively in all X-ray beam energies ranging from 50 kVp up to 18 MVp. Figure 1 shows the calculated applied dose variation through the`active' region in the blood box as predicted by the GE target II planning system. Results show that up to 6% variation in dose is expected and accepted across the active volume within the blood box for treatment of blood products. Applied dose is expected to range from 29´5 Gy to 31´7 Gy. The low doses seen at the edge of the blood box are the build up characteristics of high-energy X-ray beams (Butson et al., 1996) . Figure 2 shows the measured dose vs. applied dose in control conditions for MD-55-2 Gafchromic ®lm between the dose range 20±40 Gy. An error of 2´9% (two standard deviations of the mean) was recorded using 10 ®lms for measurement of applied dose. These results show that Gafchromic ®lm can adequately measure dose for most irradiaton procedures involving blood products. Figure 3 shows the measured applied dose for 100 consecutive blood irradiations over an 8-month period using radiochromic ®lm cut from the same batch and placed in a light-tight box for storage. Negligible effects were recorded in ®lm dosimetry deterioration as the age of the ®lm increases. Figure 4 shows a frequency histogram for the measured dose results in vitro for 100 blood irradiations. The Gafchromic ®lm was placed either on top, in the middle or below the blood bags on each occasion. The mean dose measured was 30´95 6 2´6 Gy for two standard deviation. The applied dose ranged from 29´5 Gy to 31´7 Gy with a mean applied dose of 30´85 Gy. deviation from the applied dose at isocentre was measured in 90% of all cases.
RESULTS

DISCUSSION
This study has shown that Gafchromic MD-55-2 ®lm can adequately measure dose for blood product irradiation. The ®lm can also serve as a visual marker for irradiated blood products due to its distinctive blue colour following irradiation. No reproducible differences were measured when the ®lms were placed either on top, in the middle or below the blood bags during irradiation. However, we recommend that the ®lm tags be placed at all three sites during irradiation to fully assess the 2500 cGy to midplan and no less than 15 cGy recommendation. The main considerations which must be taken into account when using radiochromic ®lm as a blood irradiation dosimeter include its slight response to ultraviolet light and scratching/contamination of the ®lm. have shown the effect of ambient/ ultraviolet light on Gafchromic MD-55-2 ®lm. The placement of the ®lm on the blood during irradiation will not affect the measured results; however, prolonged exposure (weeks of exposure) to¯uorescent lights could affect the accuracy of the measured dose. As the ®lm is measured in the visible region, effects such as scratches and contaminations, e.g. blood or ®ngerprints, could affect the optical density reading recorded. However, with careful handling these effects do not pose a problem with Gafchromic ®lm. A suggestion could be to wrap the ®lm pieces in opaque plastic during use to eliminate the above mentioned effects if contamination is considered to be a problem. With our centre, negligle effects were seen on all ®lms used due to the above mentioned problems. Meigooni et al. (1996) showed that Gafchromic ®lm could have a response nonuniformity of up to 12% on one piece of Gafchromic ®lm. Variations of this size can affect the accuracy of results if corrections are not applied. However, also have shown that the nonuniformity of Gafchromic ®lm can be as small as 1% over an entire ®lm. To assess the extent of nonuniformity for the ®lm before use, two thin strips can be cut from the sheet in both directions of the ®lms axis and irradiated to a known, uniform dose and tested. Corrections can then be applied to dose response if necessary. Radiochromic ®lm is a useful and accurate dosimeter in the measurement of absorbed dose for the irradiation of blood products. Not only can it measure dose but also can provide a visible marker for irradiated blood products.
